https://news.medxy.ai/zh/dysphagia-surgery-outcomes/Medxy AIzh2026-09-23T08:54:40-07:00衰弱是否会影响环咽肌功能障碍手术结局？——优化患者筛选与预期管理 https://news.medxy.ai/ja/pharyngeal-muscle-frailty/Medxy AIja2026-09-23T08:54:21-07:00輪状咽頭筋機能障害における手術転帰予測因子としてのフレイル：患者選択と期待値設定の最適化 https://news.medxy.ai/vi/surgery-outcomes-prediction/Medxy AIvi2026-09-23T08:54:01-07:00Suy yếu có dự báo kết quả phẫu thuật trong rối loạn chức năng cơ nhẫn hầu không? Tối ưu lựa chọn bệnh nhân và kỳ vọng điều trị https://news.medxy.ai/frailty-as-a-predictor-of-surgical-outcomes-in-cricopharyngeus-muscle-dysfunction-enhancing-patient-selection-and-expectations/Medxy AIen2026-09-23T08:53:43-07:00Frailty as a Predictor of Surgical Outcomes in Cricopharyngeus Muscle Dysfunction: Enhancing Patient Selection and Expectations https://news.medxy.ai/zh/chronic-rhinosinusitis-pathology/Medxy AIzh2026-09-23T08:53:02-07:00鼻内物质使用相关慢性鼻-鼻窦炎的组织病理学新认识：对临床管理的启示 https://news.medxy.ai/ja/77156-2/Medxy AIja2026-09-23T08:52:44-07:00鼻腔内物質に関連する慢性鼻副鼻腔炎の組織病理学的知見：臨床管理への示唆 https://news.medxy.ai/vi/chronic-rhinosinusitis-findings/Medxy AIvi2026-09-23T08:52:24-07:00Những phát hiện mô bệnh học trong viêm mũi xoang mạn tính liên quan đến sử dụng chất qua đường mũi: hàm ý cho quản lý lâm sàng https://news.medxy.ai/histopathologic-insights-in-chronic-rhinosinusitis-linked-to-intranasal-substance-use-implications-for-clinical-management/Medxy AIen2026-09-23T08:52:05-07:00Histopathologic Insights in Chronic Rhinosinusitis Linked to Intranasal Substance Use: Implications for Clinical Management https://news.medxy.ai/zh/environmental-impact-surgery/Medxy AIzh2026-09-23T08:51:28-07:00环境负担如何影响手术结局：揭开隐匿的健康差异 https://news.medxy.ai/ja/environmental-impact-surgery-2/Medxy AIja2026-09-23T08:51:14-07:00環境負荷は外科成績にどう影響するのか――見えにくい格差を読み解く https://news.medxy.ai/vi/environmental-burden-surgery-impact/Medxy AIvi2026-09-23T08:50:55-07:00Gánh nặng môi trường và tác động lên kết cục phẫu thuật: hé lộ những chênh lệch ẩn giấu https://news.medxy.ai/environmental-burden-and-its-influence-on-surgical-outcomes-unveiling-the-hidden-disparities/Medxy AIen2026-09-23T08:50:36-07:00Environmental Burden and Its Influence on Surgical Outcomes: Unveiling the Hidden Disparities https://news.medxy.ai/zh/automated-gastrectomy-quality/Medxy AIzh2026-09-23T08:49:57-07:00远端胃切除术质量评估再升级：基于计算机视觉的质量关键视野自动化判读 https://news.medxy.ai/ja/gastrectomy-quality-evaluation/Medxy AIja2026-09-23T08:49:39-07:00遠位胃切除術の手術品質評価を前進させる：Computer Vision による Critical View of Quality の自動解析 https://news.medxy.ai/vi/surgical-quality-assessment-2/Medxy AIvi2026-09-23T08:49:21-07:00Nâng tầm đánh giá chất lượng phẫu thuật trong cắt dạ dày xa: Đánh giá tự động Critical View of Quality bằng computer vision https://news.medxy.ai/advancing-surgical-quality-assessment-in-distal-gastrectomy-automated-evaluation-of-the-critical-view-of-quality-using-computer-vision/Medxy AIen2026-09-23T08:49:02-07:00Advancing Surgical Quality Assessment in Distal Gastrectomy: Automated Evaluation of the Critical View of Quality Using Computer Vision https://news.medxy.ai/zh/neurotensin-receptor1/Medxy AIzh2026-09-23T08:48:26-07:00神经降压素受体1：驱动结直肠癌免疫排斥与不良预后的关键因素 https://news.medxy.ai/ja/neurotensin-receptor1-colon-cancer/Medxy AIja2026-09-23T08:48:09-07:00ニューロテンシン受容体1が切り拓く大腸がんの免疫排除機構と予後不良の鍵 https://news.medxy.ai/vi/neurotensin-receptor-1/Medxy AIvi2026-09-23T08:47:51-07:00Thụ thể Neurotensin 1: Động lực then chốt của hiện tượng loại trừ miễn dịch và tiên lượng xấu trong ung thư đại trực tràng https://news.medxy.ai/neurotensin-receptor-1-a-key-driver-of-immune-exclusion-and-poor-prognosis-in-colorectal-cancer/Medxy AIen2026-09-23T08:47:32-07:00Neurotensin Receptor 1: A Key Driver of Immune Exclusion and Poor Prognosis in Colorectal Cancer https://news.medxy.ai/zh/early-treatment-severe-preeclampsia/Medxy AIzh2026-09-23T08:46:50-07:00早发型重度子痫前期中降压治疗升级：期待治疗期间母体风险的动态标志 https://news.medxy.ai/ja/early-severe-preeclampsia/Medxy AIja2026-09-23T08:46:33-07:00早発性重症子癇前症における降圧治療増強：待機的管理中の母体リスクを示す動的マーカー https://news.medxy.ai/vi/early-pre-eclampsia-treatment/Medxy AIvi2026-09-23T08:46:13-07:00Tăng cường điều trị hạ huyết áp trong tiền sản giật khởi phát sớm có đặc điểm nặng: chỉ dấu động về nguy cơ mẹ trong xử trí theo dõi chờ đợi https://news.medxy.ai/escalating-antihypertensive-therapy-in-early-onset-severe-preeclampsia-dynamic-marker-of-maternal-risk-during-expectant-management/Medxy AIen2026-09-23T08:45:53-07:00Escalating Antihypertensive Therapy in Early-Onset Severe Preeclampsia: Dynamic Marker of Maternal Risk During Expectant Management https://news.medxy.ai/laparoscopic-modified-davydovs-technique-for-vaginoplasty-operative-steps-and-technical-pearls/Medxy AIen2026-09-23T08:45:15-07:00Laparoscopic Modified Davydov’s Technique for Vaginoplasty: Operative Steps and Technical Pearls https://news.medxy.ai/zh/ontario-hysterectomy-trends/Medxy AIzh2026-09-23T08:44:39-07:00安大略省门诊子宫切除术的上升趋势及临床结局：基于人群的分析 https://news.medxy.ai/ja/77114-2/Medxy AIja2026-09-23T08:44:23-07:00オンタリオ州における外来子宮摘出術の増加傾向と臨床的転帰：集団ベースの解析 https://news.medxy.ai/vi/outpatient-hysterectomy-ontario/Medxy AIvi2026-09-23T08:44:05-07:00Cắt tử cung ngoại trú tại Ontario tăng nhanh cùng kết cục lâm sàng khả quan: phân tích dựa trên quần thể https://news.medxy.ai/rising-trends-and-clinical-outcomes-of-outpatient-hysterectomy-in-ontario-a-population-based-analysis/Medxy AIen2026-09-23T08:43:47-07:00Rising Trends and Clinical Outcomes of Outpatient Hysterectomy in Ontario: A Population-Based Analysis https://news.medxy.ai/zh/microbiome-necrotizing-enterocolitis/Medxy AIzh2026-09-23T08:43:10-07:00坏死性小肠结肠炎中的微生物差异机制与预测特征：肠道噬菌体与细菌耐药组的作用 https://news.medxy.ai/ja/necrotizing-enterocolitis-mechanisms/Medxy AIja2026-09-23T08:42:49-07:00壊死性腸炎における微生物機序の分岐と予測シグネチャー：腸内ファージと細菌レジストームの役割 https://news.medxy.ai/vi/77103-2/Medxy AIvi2026-09-23T08:42:25-07:00Sự phân hóa cơ chế vi sinh và các dấu ấn dự báo trong bệnh viêm ruột hoại tử: Vai trò của thể thực khuẩn đường ruột và hệ gen kháng thuốc của vi khuẩn (resistome) https://news.medxy.ai/divergent-microbial-mechanisms-and-predictive-signatures-in-necrotising-enterocolitis-the-role-of-gut-phages-and-bacterial-resistomes/Medxy AIen2026-09-23T08:42:03-07:00Divergent Microbial Mechanisms and Predictive Signatures in Necrotising Enterocolitis: The Role of Gut Phages and Bacterial Resistomes https://news.medxy.ai/zh/chronic-hepatitis-b/Medxy AIzh2026-09-23T08:41:16-07:00重新审视慢性乙型肝炎的免疫耐受期：RADICAL联盟揭示高转归率及其临床启示 https://news.medxy.ai/ja/chronic-hepatitis-b-2/Medxy AIja2026-09-23T08:40:55-07:00慢性B型肝炎の免疫寛容期を再考する：免疫活性病態への高い移行率とRADICAL consortiumが示す臨床的示唆 https://news.medxy.ai/vi/immune-tolerance-hepatitis-b/Medxy AIvi2026-09-23T08:40:33-07:00Xem xét lại pha dung nạp miễn dịch trong viêm gan B mạn tính: Tỷ lệ chuyển cao sang bệnh hoạt động miễn dịch và ý nghĩa lâm sàng từ liên minh RADICAL https://news.medxy.ai/reevaluating-immune-tolerant-phase-in-chronic-hepatitis-b-high-transition-rates-to-immune-active-disease-and-clinical-implications-from-the-radical-consortium/Medxy AIen2026-09-23T08:40:14-07:00Reevaluating Immune Tolerant Phase in Chronic Hepatitis B: High Transition Rates to Immune Active Disease and Clinical Implications from the RADICAL Consortium https://news.medxy.ai/zh/epilepsy-cause-evaluation/Medxy AIzh2026-09-23T08:39:34-07:00优化癫痫持续状态后的病因学评估：来自ICTAL登记研究的诊断获益与治疗启示 https://news.medxy.ai/ja/optimize-epilepsy-diagnosis/Medxy AIja2026-09-23T08:39:17-07:00けいれん重積状態後の病因検索を最適化する：ICTALレジストリが示す診断的有用性と治療への影響 https://news.medxy.ai/vi/epilepsy-investigation-optimization/Medxy AIvi2026-09-23T08:38:55-07:00Tối ưu hóa thăm dò căn nguyên sau trạng thái động kinh: Giá trị chẩn đoán và ý nghĩa điều trị từ sổ đăng ký ICTAL https://news.medxy.ai/optimizing-etiologic-investigations-after-status-epilepticus-diagnostic-yield-and-therapeutic-implications-from-the-ictal-registry/Medxy AIen2026-09-23T08:38:35-07:00Optimizing Etiologic Investigations After Status Epilepticus: Diagnostic Yield and Therapeutic Implications from the ICTAL Registry https://news.medxy.ai/ja/77090-2/Medxy AIja2026-09-23T08:37:32-07:00アルツハイマー病におけるタウPET病期分類のための統合的目視読影フレームワーク https://news.medxy.ai/vi/harmonious-image-reading/Medxy AIvi2026-09-23T08:37:12-07:00Một khung đọc hình ảnh hài hòa để phân giai đoạn Tau PET trong bệnh Alzheimer https://news.medxy.ai/a-harmonized-visual-reading-framework-for-tau-pet-staging-in-alzheimer-disease/Medxy AIen2026-09-23T08:36:54-07:00A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease https://news.medxy.ai/ja/quantitative-insights/Medxy AIja2026-09-23T08:34:57-07:00縦断的システムモデリングで読み解くチルゼパチドとセマグルチドの定量的知見 https://news.medxy.ai/vi/tirzepatide-semaglutide-power/Medxy AIvi2026-09-23T08:34:40-07:00Tiết lộ sức mạnh của Tirzepatide và Semaglutide qua mô hình hệ thống dọc https://news.medxy.ai/quantitative-insights-into-tirzepatide-and-semaglutide-using-longitudinal-systems-modeling/Medxy AIen2026-09-23T08:34:22-07:00Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling https://news.medxy.ai/zh/77077-2/Medxy AIzh2026-09-23T08:33:44-07:00PPARγ激动剂与GLP-1受体激动剂在中枢神经系统胰岛素抵抗中的作用 https://news.medxy.ai/ja/brain-metabolism-biomarkers/Medxy AIja2026-09-23T08:33:23-07:00神経由来細胞外小胞バイオマーカーから読む脳代謝：CNSインスリン抵抗性におけるPPARγ作動薬とGLP1受容体作動薬の役割 https://news.medxy.ai/vi/neuron-exosome-biomarkers/Medxy AIvi2026-09-23T08:32:59-07:00Dấu ấn sinh học từ túi ngoại bào nguồn gốc neuron: PPARγ và chất chủ vận thụ thể GLP1 điều biến chuyển hóa não trong kháng insulin của CNS https://news.medxy.ai/brain-metabolism-insights/Medxy AIen2026-09-23T08:32:37-07:00Insights from Neuron-Derived Extracellular Vesicle Biomarkers: PPARγ and GLP1 Receptor Agonists Modulate Brain Metabolism in CNS Insulin Resistance https://news.medxy.ai/zh/pediatric-thyroid-cancer/Medxy AIzh2026-09-23T08:31:45-07:00儿童分化型甲状腺癌：来自儿童与青少年甲状腺联盟的侵袭性疾病预测因素及治疗结局洞见 https://news.medxy.ai/ja/pediatric-thyroid-cancer-2/Medxy AIja2026-09-23T08:31:28-07:00小児分化型甲状腺癌：CATCが示す浸潤性病変の予測因子と治療成績 https://news.medxy.ai/vi/differentiated-thyroid-cancer-children/Medxy AIvi2026-09-23T08:31:06-07:00Ung thư tuyến giáp biệt hóa ở trẻ em: phát hiện từ Child and Adolescent Thyroid Consortium về các yếu tố dự báo bệnh xâm lấn và kết quả điều trị https://news.medxy.ai/pediatric-differentiated-thyroid-carcinoma-insights-from-the-child-and-adolescent-thyroid-consortium-on-invasive-disease-predictors-and-treatment-outcomes/Medxy AIen2026-09-23T08:30:48-07:00Pediatric Differentiated Thyroid Carcinoma: Insights from the Child and Adolescent Thyroid Consortium on Invasive Disease Predictors and Treatment Outcomes https://news.medxy.ai/zh/type-1-diabetes-risk/Medxy AIzh2026-09-23T08:30:08-07:001型糖尿病发病年龄越早，死亡与并发症风险越高：来自瑞典全国队列的研究启示 https://news.medxy.ai/ja/type-1-diabetes-age-onset/Medxy AIja2026-09-23T08:29:50-07:001型糖尿病は何歳で発症したかが予後を左右する：スウェーデン全国コホートが示す死亡・臓器合併症への影響 https://news.medxy.ai/vi/type-1-diabetes-age/Medxy AIvi2026-09-23T08:29:28-07:00Tuổi khởi phát đái tháo đường týp 1: yếu tố quyết định tiên lượng tử vong và biến chứng cơ quan từ dữ liệu đoàn hệ toàn quốc Thụy Điển https://news.medxy.ai/impact-of-age-at-type-1-diabetes-onset-on-mortality-and-organ-complications-insights-from-a-nationwide-swedish-cohort/Medxy AIen2026-09-23T08:29:07-07:00Impact of Age at Type 1 Diabetes Onset on Mortality and Organ Complications: Insights from a Nationwide Swedish Cohort https://news.medxy.ai/zh/empagliflozin-cv-benefits/Medxy AIzh2026-09-23T08:28:24-07:00恩格列净在2型糖尿病不同患者亚组中均显示一致的心血管获益：EMPRISE真实世界研究启示 https://news.medxy.ai/ja/empagliflozin-cv-benefits-2/Medxy AIja2026-09-23T08:28:04-07:00エンパグリフロジンは2型糖尿病の多様な患者集団で一貫した心血管利益を示す：EMPRISEリアルワールド研究からの知見 https://news.medxy.ai/vi/77045-2/Medxy AIvi2026-09-23T08:27:44-07:00Empagliflozin đã cho thấy lợi ích tim mạch nhất quán trên các phân nhóm bệnh nhân đái tháo đường tuýp 2 khác nhau https://news.medxy.ai/empagliflozin-demonstrates-uniform-cardiovascular-benefits-across-diverse-patient-subgroups-in-type-2-diabetes-insights-from-the-emprise-real-world-study/Medxy AIen2026-09-23T08:27:24-07:00Empagliflozin Demonstrates Uniform Cardiovascular Benefits Across Diverse Patient Subgroups in Type 2 Diabetes: Insights from the EMPRISE Real-World Study https://news.medxy.ai/zh/ttn-truncation-screening/Medxy AIzh2026-09-23T08:26:43-07:00携带TTN截断变异亲属的个体化筛查间隔：优化扩张型心肌病管理 https://news.medxy.ai/ja/ttn-mutation-screening/Medxy AIja2026-09-23T08:26:26-07:00TTN切断変異保有家族のスクリーニング間隔を個別化：拡張型心筋症管理の精緻化 https://news.medxy.ai/vi/77035-2/Medxy AIvi2026-09-23T08:26:07-07:00Cá nhân hóa khoảng thời gian sàng lọc cho các gia đình mang đột biến cắt cụt gen TTN: Tối ưu hóa việc quản lý bệnh cơ tim giãn https://news.medxy.ai/tailored-screening-intervals-for-relatives-carrying-ttn-truncations-enhancing-dilated-cardiomyopathy-management/Medxy AIen2026-09-23T08:25:48-07:00Tailored Screening Intervals for Relatives Carrying TTN Truncations: Enhancing Dilated Cardiomyopathy Management https://news.medxy.ai/zh/elderly-heart-transplant-quality/Medxy AIzh2026-09-23T08:25:07-07:00老年患者接受心脏移植或机械循环支持后的长期生活质量结局：来自 SUSTAIN-IT 研究的启示 https://news.medxy.ai/ja/77028-2/Medxy AIja2026-09-23T08:24:50-07:00高齢患者における心臓移植または機械的循環補助後の長期的なQOL（生活の質）の転帰 https://news.medxy.ai/vi/77027-2/Medxy AIvi2026-09-23T08:24:32-07:00Kết quả chất lượng cuộc sống dài hạn ở bệnh nhân cao tuổi sau ghép tim hoặc hỗ trợ tuần hoàn cơ học https://news.medxy.ai/long-term-quality-of-life-outcomes-in-older-patients-undergoing-heart-transplantation-or-mechanical-circulatory-support-insights-from-the-sustain-it-study/Medxy AIen2026-09-23T08:24:13-07:00Long-Term Quality of Life Outcomes in Older Patients Undergoing Heart Transplantation or Mechanical Circulatory Support: Insights from the SUSTAIN-IT Study https://news.medxy.ai/zh/clonal-hematopoiesis-hfpef/Medxy AIzh2026-09-23T08:23:37-07:00借助克隆性造血蛋白组学特征预测HFpEF预后 https://news.medxy.ai/ja/clonal-hematopoiesis-hfpef-2/Medxy AIja2026-09-23T08:23:17-07:00HFpEFの予後予測に挑むクローン性造血プロテオームシグネチャーの活用 https://news.medxy.ai/vi/hematopoiesis-proteome-hfpef/Medxy AIvi2026-09-23T08:22:54-07:00Khai thác dấu ấn proteome của tạo máu dòng vô tính để dự đoán tiên lượng trong HFpEF https://news.medxy.ai/leveraging-proteomic-signatures-of-clonal-hematopoiesis-to-predict-outcomes-in-hfpef/Medxy AIen2026-09-23T08:22:34-07:00Leveraging Proteomic Signatures of Clonal Hematopoiesis to Predict Outcomes in HFpEF https://news.medxy.ai/zh/balanced-crystalloids-sepsis-2/Medxy AIzh2026-09-23T07:56:50-07:00ICU前使用平衡晶体液或可降低脓毒症病死率：大型多中心队列研究揭示早期补液优势 https://news.medxy.ai/ja/balanced-crystalloids-sepsis/Medxy AIja2026-09-23T07:56:30-07:00敗血症のICU入室前輸液は平衡晶質液が有利：大規模多施設コホート研究から見えた死亡率低下 https://news.medxy.ai/vi/76996-2/Medxy AIvi2026-09-23T07:56:11-07:00Việc sử dụng dịch tinh thể cân bằng trước khi nhập vào đơn vị hồi sức tích cực (ICU) có thể làm giảm tỷ lệ tử vong do nhiễm khuẩn huyết https://news.medxy.ai/pre-icu-balanced-crystalloids-reduce-mortality-in-sepsis-insights-from-a-large-multicenter-cohort-study/Medxy AIen2026-09-23T07:55:52-07:00Pre-ICU Balanced Crystalloids Reduce Mortality in Sepsis: Insights from a Large Multicenter Cohort Study https://news.medxy.ai/zh/us-noniu-uveitis-rise/Medxy AIzh2026-09-23T07:55:12-07:00美国非感染性儿童葡萄膜炎发病率持续上升：基于十年 TriNetX 数据的临床洞见 https://news.medxy.ai/ja/76992-2/Medxy AIja2026-09-23T07:54:54-07:00米国における小児の非感染性ぶどう膜炎の発生率が上昇し続けている https://news.medxy.ai/vi/noninfectious-uveitis-kids-us/Medxy AIvi2026-09-23T07:54:33-07:00Gia tăng tỷ lệ và mức độ phức tạp lâm sàng của viêm màng bồ đào không do nhiễm trùng ở trẻ em tại Hoa Kỳ: Kết quả từ 10 năm dữ liệu TriNetX https://news.medxy.ai/rising-incidence-and-clinical-complexity-of-non-infectious-pediatric-uveitis-in-the-us-insights-from-a-decade-of-trinetx-data/Medxy AIen2026-09-23T07:54:14-07:00Rising Incidence and Clinical Complexity of Non-Infectious Pediatric Uveitis in the US: Insights from a Decade of TriNetX Data https://news.medxy.ai/zh/76987-2/Medxy AIzh2026-09-23T07:53:42-07:00视网膜母细胞瘤集中式多学科诊疗：利用远程医疗与先进眼球保留技术缩小资源匮乏地区的疗效差距 https://news.medxy.ai/ja/retinoblastoma-telemedicine/Medxy AIja2026-09-23T07:53:18-07:00遠隔医療で広がる網膜芽細胞腫の集約診療：資源制約下で生存率と眼球温存率を高める https://news.medxy.ai/vi/retinoblastoma-care/Medxy AIvi2026-09-23T07:52:52-07:00Chăm sóc u nguyên bào võng mạc tập trung, đa chuyên khoa: Thu hẹp khoảng cách kết cục bằng telemedicine và các liệu pháp bảo tồn nhãn cầu tiên tiến https://news.medxy.ai/centralized-multidisciplinary-retinoblastoma-care-closing-outcome-gaps-in-resource-limited-settings-with-telemedicine-and-advanced-globe-salvage/Medxy AIen2026-09-23T07:52:28-07:00Centralized Multidisciplinary Retinoblastoma Care: Closing Outcome Gaps in Resource-Limited Settings with Telemedicine and Advanced Globe Salvage https://news.medxy.ai/zh/lymphatic-invasion/Medxy AIzh2026-09-23T07:51:36-07:00淋巴血管侵犯：喉鳞状细胞癌独立预后标志物——来自国家队列研究的证据 https://news.medxy.ai/ja/lymphovascular-invasion/Medxy AIja2026-09-23T07:51:19-07:00喉頭扁平上皮癌における独立予後因子としてのリンパ血管侵襲：全国コホート研究からの示唆 https://news.medxy.ai/vi/76973-2/Medxy AIvi2026-09-23T07:50:57-07:00Xâm lấn mạch bạch huyết – mạch máu là một yếu tố tiên lượng độc lập đối với ung thư biểu mô tế bào vảy thanh quản https://news.medxy.ai/lymphovascular-invasion-as-an-independent-prognostic-marker-in-laryngeal-squamous-cell-carcinoma-insights-from-a-national-cohort-study/Medxy AIen2026-09-23T07:50:37-07:00Lymphovascular Invasion as an Independent Prognostic Marker in Laryngeal Squamous Cell Carcinoma: Insights from a National Cohort Study https://news.medxy.ai/zh/76967-2/Medxy AIzh2026-09-23T07:50:03-07:00早产型子痫前期期待治疗中的蛋白尿：预测妊娠结局的预后指标 https://news.medxy.ai/ja/proteinuria-preeclampsia-management/Medxy AIja2026-09-23T07:49:44-07:00早産性子癇前症の期待的管理における蛋白尿：妊娠転帰を見通す予後指標 https://news.medxy.ai/vi/proteinuria-preeclampsia/Medxy AIvi2026-09-23T07:49:24-07:00Protein niệu như một dấu ấn tiên lượng trong tiền sản giật non tháng được xử trí chờ đợi https://news.medxy.ai/proteinuria-as-a-prognostic-marker-for-pregnancy-outcomes-in-preterm-pre-eclampsia-during-expectant-management/Medxy AIen2026-09-23T07:49:04-07:00Proteinuria as a Prognostic Marker for Pregnancy Outcomes in Preterm Pre-Eclampsia During Expectant Management https://news.medxy.ai/zh/76961-2/Medxy AIzh2026-09-23T07:48:30-07:00卵巢癌一级预防中的单纯输卵管切除术：成本效益分析 https://news.medxy.ai/ja/salpingectomy-cost-effectiveness/Medxy AIja2026-09-23T07:48:12-07:00卵巣がん一次予防における単独卵管切除術：費用対効果の検討 https://news.medxy.ai/vi/76957-2/Medxy AIvi2026-09-23T07:47:51-07:00Phẫu thuật cắt vòi tử cung đơn thuần trong dự phòng cấp 1 ung thư buồng trứng: Đánh giá hiệu quả chi phí https://news.medxy.ai/standalone-salpingectomy-for-primary-ovarian-cancer-prevention-a-cost-effectiveness-analysis/Medxy AIen2026-09-23T07:47:28-07:00Standalone Salpingectomy for Primary Ovarian Cancer Prevention: A Cost-Effectiveness Analysis https://news.medxy.ai/zh/whole-grain-intake-heart-risk/Medxy AIzh2026-09-23T07:33:04-07:00全谷物摄入与心代谢风险：随机对照试验 Meta 分析证据 https://news.medxy.ai/ja/whole-grain-intake/Medxy AIja2026-09-23T07:32:43-07:00全粒穀物摂取と心血管代謝リスク：ランダム化比較試験のメタ解析からのエビデンス https://news.medxy.ai/vi/whole-grains-heart-risk-2/Medxy AIvi2026-09-23T07:32:14-07:00Ngũ cốc nguyên hạt và nguy cơ tim mạch-chuyển hóa: Bằng chứng từ phân tích tổng hợp các thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/whole-grain-consumption-and-cardiometabolic-risk-evidence-from-meta-analyses-of-randomized-controlled-trials/Medxy AIen2026-09-23T07:31:51-07:00Whole-Grain Consumption and Cardiometabolic Risk: Evidence from Meta-Analyses of Randomized Controlled Trials https://news.medxy.ai/zh/tenecteplase-bleeding-risk/Medxy AIzh2026-09-23T07:21:52-07:00替奈普酶溶栓后脑内出血风险：关键危险因素与临床预警模型 https://news.medxy.ai/ja/intracranial-bleeding-risk/Medxy AIja2026-09-23T07:21:32-07:00急性心筋梗塞におけるテネクテプラーゼ線溶療法後頭蓋内出血の危険因子とその低減戦略 https://news.medxy.ai/vi/hemorrhage-risk-reduction/Medxy AIvi2026-09-23T07:21:10-07:00Nhận diện và giảm thiểu các yếu tố nguy cơ xuất huyết nội sọ sau tiêu sợi huyết bằng tenecteplase trong nhồi máu cơ tim cấp https://news.medxy.ai/identifying-and-mitigating-risk-factors-for-intracranial-haemorrhage-following-tenecteplase-fibrinolysis-in-acute-myocardial-infarction/Medxy AIen2026-09-23T07:20:50-07:00Identifying and Mitigating Risk Factors for Intracranial Haemorrhage Following Tenecteplase Fibrinolysis in Acute Myocardial Infarction https://news.medxy.ai/emergency-medical-services-equipment-use-in-the-emergency-department-and-its-impact-on-time-to-care-in-out-of-hospital-cardiac-arrest-patients/Medxy AIen2026-09-23T05:54:42-07:00Emergency Medical Services Equipment Use in the Emergency Department and Its Impact on Time to Care in Out-of-Hospital Cardiac Arrest Patients https://news.medxy.ai/zh/escc-pd-l1-therapy/Medxy AIzh2026-09-22T07:46:42-07:00解码细胞互作，提升食管鳞状细胞癌新辅助PD-L1阻断疗效 https://news.medxy.ai/ja/pd-l1-therapy-response/Medxy AIja2026-09-22T07:46:26-07:00食道扁平上皮癌における術前PD-L1遮断療法の反応を読み解く細胞間相互作用 https://news.medxy.ai/vi/cell-interaction-pd-l1/Medxy AIvi2026-09-22T07:46:06-07:00Giải mã tương tác tế bào để tăng cường đáp ứng ức chế PD-L1 tân bổ trợ trong ung thư biểu mô tế bào vảy thực quản https://news.medxy.ai/decoding-cellular-interactions-to-enhance-neoadjuvant-pd-l1-blockade-response-in-esophageal-squamous-cell-carcinoma/Medxy AIen2026-09-22T07:45:48-07:00Decoding Cellular Interactions to Enhance Neoadjuvant PD-L1 Blockade Response in Esophageal Squamous Cell Carcinoma https://news.medxy.ai/zh/carotid-dissection-stroke/Medxy AIzh2026-09-22T07:45:14-07:00颅颈动脉夹层后卒中复发的时间规律与形态学预测因素 https://news.medxy.ai/ja/stroke-recurrence-after-dissection/Medxy AIja2026-09-22T07:44:57-07:00頭蓋頸部動脈解離後の脳卒中再発：時間的推移と画像形態による予測因子 https://news.medxy.ai/vi/stroke-recurrence-prediction-5/Medxy AIvi2026-09-22T07:44:36-07:00Động học theo thời gian và các yếu tố hình thái dự báo tái phát đột quỵ sau bóc tách động mạch sọ-cổ https://news.medxy.ai/temporal-dynamics-and-morphological-predictors-of-stroke-recurrence-after-craniocervical-artery-dissection/Medxy AIen2026-09-22T07:44:16-07:00Temporal Dynamics and Morphological Predictors of Stroke Recurrence After Craniocervical Artery Dissection https://news.medxy.ai/zh/cushing-syndrome-lipid-worsening-2/Medxy AIzh2026-09-22T07:43:42-07:00库欣综合征术后早期血脂反常恶化：对心血管风险管理的启示 https://news.medxy.ai/ja/cushing-syndrome-lipid-worsening/Medxy AIja2026-09-22T07:43:25-07:00クッシング症候群の術後早期にみられる脂質悪化：心血管リスク評価と管理への示唆 https://news.medxy.ai/vi/cushing-syndrome-lipids/Medxy AIvi2026-09-22T07:43:05-07:00Hội chứng Cushing: Rối loạn lipid có thể nặng hơn sớm sau mổ và hàm ý nguy cơ tim mạch https://news.medxy.ai/early-lipid-deterioration/Medxy AIen2026-09-22T07:42:46-07:00Unexpected Early Postoperative Lipid Deterioration in Cushing’s Syndrome: Implications for Cardiovascular Risk and Management https://news.medxy.ai/ja/gene-editing-cvd/Medxy AIja2026-09-22T07:42:12-07:00心血管疾患における遺伝子編集療法：2026年ACC声明の重要ポイント https://news.medxy.ai/vi/76924-2/Medxy AIvi2026-09-22T07:41:38-07:00Các liệu pháp chỉnh sửa gen cho bệnh tim mạch: Những điểm chính từ Tuyên bố Khoa học năm 2026 của ACC https://news.medxy.ai/zh/cardiovascular-gene-editing/Medxy AIzh2026-09-22T07:41:02-07:00心血管疾病基因编辑治疗：2026 年 ACC 科学声明要点解读